| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |